Alexey A. Lugovskoy
Chief Executive Officer at Diagonal Therapeutics, Inc.
Profile
Alexey A.
Lugovskoy is the founder and the Chief Executive Officer of Diagonal Therapeutics, Inc., which was founded in 2022.
He is also currently an Advisory Board Member at RusBioVentures LLC since 2013.
In the past, Dr. Lugovskoy held the position of Associate Director-Drug Discovery at Biogen, Inc. from 2001 to 2010.
He then served as Vice President-Therapeutics at Merrimack Pharmaceuticals, Inc. from 2010 to 2016.
Additionally, he held the role of Chief Development Officer at Morphic Holding, Inc. and Chief Operating Officer at Dragonfly Therapeutics, Inc.Dr. Lugovskoy's education includes a doctorate degree from Harvard University.
He also holds a graduate degree from the Massachusetts Institute of Technology, where he graduated in 1998.
He completed his undergraduate and graduate studies at Moscow Institute of Physics & Technology, and received his undergraduate degree from Ryazan State Radio Technical University in 1992.
Alexey A. Lugovskoy active positions
| Companies | Position | Start |
|---|---|---|
RusBioVentures LLC
 RusBioVentures LLC Investment ManagersFinance RusBioVentures LLC (RBV Capital) is a venture capital firm founded in 2014 by Alexey Konov. The firm is headquartered in Moscow, Russia. | Consultant / Advisor | 31/12/2012 |
Diagonal Therapeutics, Inc.
 Diagonal Therapeutics, Inc. BiotechnologyHealth Technology Diagonal Therapeutics, Inc. is a biotechnology company located in the US that develops drugs for oncology, immunology, and rare diseases. | Chief Executive Officer | 31/12/2021 |
Former positions of Alexey A. Lugovskoy
| Companies | Position | End |
|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/12/2015 |
| BIOGEN INC. | Corporate Officer/Principal | 31/05/2010 |
Dragonfly Therapeutics, Inc.
 Dragonfly Therapeutics, Inc. BiotechnologyHealth Technology Dragonfly Therapeutics, Inc. develops therapy to stimulate immune responses against cancer. The company was founded by Tyler Jacks, Bill Haney and David Raulet in 2015 and is headquartered in Waltham, MA. | Chief Operating Officer | - |
| MORPHIC HOLDING, INC. | Corporate Officer/Principal | - |
Training of Alexey A. Lugovskoy
| Harvard University | Doctorate Degree |
| Moscow Institute of Physics & Technology | Graduate Degree |
| Massachusetts Institute of Technology | Graduate Degree |
| Ryazan State Radio Technical University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MORPHIC HOLDING, INC. | Health Technology |
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Private companies | 3 |
|---|---|
Dragonfly Therapeutics, Inc.
Dragonfly Therapeutics, Inc. BiotechnologyHealth Technology Dragonfly Therapeutics, Inc. develops therapy to stimulate immune responses against cancer. The company was founded by Tyler Jacks, Bill Haney and David Raulet in 2015 and is headquartered in Waltham, MA. | Health Technology |
RusBioVentures LLC
RusBioVentures LLC Investment ManagersFinance RusBioVentures LLC (RBV Capital) is a venture capital firm founded in 2014 by Alexey Konov. The firm is headquartered in Moscow, Russia. | Finance |
Diagonal Therapeutics, Inc.
Diagonal Therapeutics, Inc. BiotechnologyHealth Technology Diagonal Therapeutics, Inc. is a biotechnology company located in the US that develops drugs for oncology, immunology, and rare diseases. | Health Technology |
- Stock Market
- Insiders
- Alexey A. Lugovskoy
